Agenda

We would like to thank our exhibitors for sponsoring this meeting, which includes pharmaceutical companies including AstraZeneca UK. They have had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the sponsored symposia presentations.

Tuesday, October 1, 2024
9:20 AM - 10:15 AM
Chair’s opening remarks followed by: Cardio-Oncology: Harmonizing heart and cancer care
  • The impact of systemic anti-cancer therapy on the cardiovascular system
  •  Assessing cardiovascular risk and why it’s important
  •  Collaborative care and coordination of the MDT in cardio-oncology
 
 
 
10:30 AM - 11:15 AM
Enabling optimisation of four pillars in heart failure
 
This is a promotional symposium sponsored and organised by AstraZeneca, intended for GB HCPs only.
Enabling optimisation of four pillars in heart failure
 
11:30 AM - 12:15 PM
Simplifying the management of heart failure across the range of ejection fraction
 
This is a promotional symposium sponsored and organised by AstraZeneca, intended for GB HCPs only.
Simplifying the management of heart failure across the range of ejection fraction
 
12:30 PM - 1:15 PM
The changing landscape of cardiovascular disease and the challenge of prevention
  •  Preventing cardiovascular disease, such as hypertension
  •  Risk factors and how to address them with patients
  •  Specific risks of CVD in diabetes, obesity and smoking
 
 
 
1:30 PM - 2:15 PM
Managing ventricular arrhythmia: innovations and best practices
  •  Diagnosing ventricular arrhythmia
  • Pharmacological and non-pharmacological treatments for management
  • Indications for catheter ablation and device therapy, e.g. implantable cardioverter-defibrillators.
 
 
 
2:30 PM - 3:15 PM
Panel Discussion: Advances in interventional cardiology
  •  Techniques, procedures and devices currently being used
  •  Examples including coronary artery disease, valvular heart disease and structural heart conditions
 
 
 
3:30 PM - 4:15 PM
Cardiomyopathy - Diagnosis and management
  •  A review of the different types of cardiomyopathy
  •  Clinical presentations and diagnostic criteria
  •  Management and treatment
 
 
 
4:15 PM
End of conference
 
 
 
 

Speakers

Helena Beer
Helena Beer
Cogora
Editor, Hospital Healthcare Europe, Hospital Pharmacy Europe
Dr Sarah Birkhoelzer
Dr Sarah Birkhoelzer
Cardiology Registrar, Clinical Research Fellow at Oxford Centre for Clinical Magnetic Resonance Research, Oxford University
Pierluigi Constanzo
Pierluigi Constanzo
Consultant Interventional and Structural Cardiology, Clinical Lead for Coronary Intervention, Royal Papworth Hospital NHS Foundation Trust
Rebecca Dobson
Rebecca Dobson
Consultant Cardiologist (Imaging & Cardio-Oncology), Liverpool Heart and Chest Hospital
Brian Halliday
Brian Halliday
Consultant Cardiologist, Clinical Senior Lecturer in Cardiomyopathy and CMR, BHF Intermediate Fellow, Royal Brompton and Harefield Hospitals and National Heart and Lung Institute
Sundeep Kalra
Sundeep Kalra
Consultant Cardiologist, Royal Free Hospital
Kazem Rahmini
Kazem Rahmini
Honorary Consultant Cardiologist, Oxford University Hospitals NHS Trust
Professor of Cardiovascular Medicine and Population Health, Deep Medicine, Nuffield Department of Womens’ and Reproductive Health, University of Oxford
John Whitaker
John Whitaker
Senior Lecturer, Honorary Consultant Cardiologist and Electrophysiologist, King's College London, Guys and St Thomas' Foundation Trust
Rhys Williams
Rhys Williams
Cardiology Pharmacist, Cwm Taf Morgannwg University Health Board
Alex Zaphirou
Alex Zaphirou
Consultant in Interventional Cardiology, University Hospitals Birmingham- Queen Elizabeth Hospital